Hyperbaric oxygen therapy for veterans with traumatic brain injury
Official title: Hyperbaric Oxygen Treatment for Veterans With Traumatic Brain Injury
Run by University of South Florida · NCT06581003 · Data updated 2026-11-12
This study is testing if hyperbaric oxygen therapy can help veterans and active military personnel with mild to moderate traumatic brain injuries feel better and reduce symptoms of PTSD.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 420 (estimated) |
| Sponsor | University of South Florida Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Tampa, Florida) |
| Status | Recruiting |
| Started | September 18, 2024 |
| Main results expected | August 15, 2028 |
| Study ends | August 15, 2029 |
| Registry record updated | July 15, 2026 |
| Trial ID | NCT06581003 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are U.S. service members and veterans aged 18 to 75 with a history of mild to moderate traumatic brain injury.
✕Probably not a fit
Patients who have received hyperbaric oxygen therapy within the last three months or have certain medical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of hyperbaric oxygen therapy (HBOT) in treating mild to moderate traumatic brain injury (TBI) in veterans and active military personnel. It is a blinded, adaptive, randomized, placebo-controlled trial that aims to determine if HBOT can reduce neurobehavioral symptoms and PTSD symptoms, as well as explore various cognitive and biological changes. Participants will undergo comprehensive assessments and be randomized to receive either HBOT or a placebo treatment. The study will also evaluate the number of HBOT sessions needed for significant symptom reduction.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the quality of life for veterans suffering from traumatic brain injury and related symptoms.
How similar studies have gone: While some studies have explored hyperbaric oxygen therapy for various conditions, this specific application for veterans with TBI is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. U.S. Service Members and Veterans, between 18 and 75 years of age 2. Ability to read, write, and speak English. 3. Ability to provide informed consent. 4. History of TBI. Participants must have a minimum of 1 year post injury and a TBI classified as mild to moderate as determined by with the Ohio State University TBI Identification Method (Bogner, 2009). 5. Experiencing chronic symptoms of TBI as determined by at least a NSI total score of ≥22 (based on previous work using this score; Harch et al., 2020. 6. Able to tolerate the HBOT environment lying down for one hour. Exclusion Criteria: 1. Received HBOT within the last 3 months. 2. Concurrently enrolled in another clinical trial. 3. Pregnancy or plans to become pregnant during the study period. 4. Lactating 5. History of retinal repair 6. Malignancy: 1. Active 2. Tumor-related chemotherapy within the prior 6 months 3. Therapeutic radiation to the central nervous system within the prior year 7. Current diagnosis of bipolar disorder type I or schizophrenia as determined by responses to inquiry: Have you ever been diagnosed or prescribed medications for bipolar disorder or schizophrenia? 8. Chronic use of supplemental oxygen or hypoxemia while breathing room air. 9. Untreated asthma/Bronchial obstruction/pulmonary blebs, recent/untreated pneumothorax 10. Congestive heart failure with ejection fraction \< 40% 11. Any implanted devices not cleared for hyperbaric pressurization\*. 12. Epilepsy and/ or seizures 13. Scuba diving within the previous month 14. Current suicidal intent as measured by ≥ 3 on the Columbia-Suicide Severity Rating Scale Screener 15. Trapped gas observed indicating Bronchospasm present Tension Pneumothorax 16. Evidence of Noncompliant TM (Until corrected) 17. Evidence of Pneumothorax 18. Evidence of Upper Respiratory Tract Infections 19. Signs and symptoms of viral infections, such as high fevers 20. Emphysema with CO2 retention 21. Optic Neuritis 22. Congenital spherocytosis 23. History of middle ear surgery / disorders 24. Pneumocephalus 25. Optional stool samples will not be collected if someone has diarrhea, vomiting, and took antibiotics in the past 30 days. 26. Antabuse because it predisposes to oxygen toxicity. 27. Other medications that would predispose to oxygen toxicity or known to increase drug toxicity will also be excluded. These are: Disulfuram, Acetazolamide, Sulfamylon; bleomycin, cisplatin, and doxyrubicin. 28. Inability to complete MRIs (e.g., claustrophobia, pacemaker, ferromagnetic implants)\* Exclusion criteria for fMRI optional sub-study only
Where it's running
-
University of South Florida
Tampa, Florida, United States Recruiting
Study contacts
- Study coordinator: Erik Velasquez
- Email: erikv@usf.edu
- Phone: 813-905-1043
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PIONEER-Prognosis: Using biomarkers and wearables to forecast recovery after mild traumatic brain injury
This study tests whether blood biomarkers, health data from records, and wearables can help predict how people recover after a mild traumatic brain injury treated in the emergency department.
-
HBOT to see if it helps cognition and well‑being in first responders with prior brain injury
This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.
-
Depth Electrode Monitoring after Traumatic Brain Injury
This study tests adding a depth electrode with continuous brain monitoring during external ventricular drain placement in adults with traumatic brain injury to see if cortical reverberation signals can be tracked safely.
-
Understanding growth hormone deficiency after a brain injury in adults
This observational study tests whether growth hormone deficiency affects quality of life and symptoms in adults with traumatic brain injury and whether GH replacement helps after 12 weeks.
-
Electrical stimulation-assisted exercise for people with lower limb paralysis
This study tests whether adding electrical stimulation during exercise can improve leg muscle strength and endurance for people with paralysis.
-
ZEPU-2000 robotic rehab for arm and leg weakness
This trial tests whether adding ZEPU-2000A, ZEPU-2000D, and ZEPU-2000E robotic rehabilitation to usual therapy helps adults with arm/leg movement problems from stroke, incomplete SCI, TBI, or related conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.